141 related articles for article (PubMed ID: 15008125)
1. Protease mutations in HIV-1 non-B strains infecting drug-naive villagers in Cameroon.
Konings FA; Zhong P; Agwara M; Agyingi L; Zekeng L; Achkar JM; Ewane L; Saa ; Afane Ze E; Kinge T; Nyambi PN
AIDS Res Hum Retroviruses; 2004 Jan; 20(1):105-9. PubMed ID: 15008125
[TBL] [Abstract][Full Text] [Related]
2. Distinct resistance mutation and polymorphism acquisition in HIV-1 protease of subtypes B and F1 from children and adult patients under virological failure.
Dumans AT; Barreto CC; Santos AF; Arruda M; Sousa TM; Machado ES; Sabino EC; Brindeiro RM; Tanuri A; Duarte AJ; Soares MA
Infect Genet Evol; 2009 Jan; 9(1):62-70. PubMed ID: 18992847
[TBL] [Abstract][Full Text] [Related]
3. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
[TBL] [Abstract][Full Text] [Related]
4. Identification and distribution of HIV type 1 genetic diversity and protease inhibitor resistance-associated mutations in Shanghai, P. R. China.
Zhong P; Kang L; Pan Q; Konings F; Burda S; Ma L; Xue Y; Zheng X; Jin Z; Nyambi P
J Acquir Immune Defic Syndr; 2003 Sep; 34(1):91-101. PubMed ID: 14501800
[TBL] [Abstract][Full Text] [Related]
5. Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients.
Vergne L; Peeters M; Mpoudi-Ngole E; Bourgeois A; Liegeois F; Toure-Kane C; Mboup S; Mulanga-Kabeya C; Saman E; Jourdan J; Reynes J; Delaporte E
J Clin Microbiol; 2000 Nov; 38(11):3919-25. PubMed ID: 11060045
[TBL] [Abstract][Full Text] [Related]
6. Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.
Bellocchi MC; Forbici F; Palombi L; Gori C; Coelho E; Svicher V; D'Arrigo R; Emberti-Gialloreti L; Ceffa S; Erba F; Marazzi MC; Silberstein FC; Perno CF
J Med Virol; 2005 Aug; 76(4):452-8. PubMed ID: 15977236
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of drug resistance-related polymorphisms in treatment-naive individuals infected with nonsubtype B HIV type 1 in Cameroon.
Youngpairoj AS; Alemnji GA; Eno LT; Lyonga EJ; Eloundou MA; Shanmugam V; Mpoudi EN; Folks TM; Kalish ML; Pieniazek D; Fonjungo PN
AIDS Res Hum Retroviruses; 2012 Jul; 28(7):675-84. PubMed ID: 21923557
[TBL] [Abstract][Full Text] [Related]
8. Zero prevalence of primary drug resistance-associated mutations to protease inhibitors in HIV-1 drug-naive patients in and around Aligarh, India.
Azam M; Malik A; Rizvi M; Rai A
J Infect Dev Ctries; 2014 Jan; 8(1):79-85. PubMed ID: 24423716
[TBL] [Abstract][Full Text] [Related]
9. Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy.
Brindeiro PA; Brindeiro RM; Mortensen C; Hertogs K; De Vroey V; Rubini NP; Sion FS; De Sá CA; Machado DM; Succi RC; Tanuri A
J Clin Microbiol; 2002 Dec; 40(12):4512-9. PubMed ID: 12454144
[TBL] [Abstract][Full Text] [Related]
10. Natural polymorphisms of protease in protease inhibitor-naive HIV-1 infected patients in Korea: a novel L63M in subtype B.
Sung H; Foley BT; Ahn SH; Kim YB; Chae JD; Shin YO; Kang HI; Cho YK
AIDS Res Hum Retroviruses; 2003 Jun; 19(6):525-30. PubMed ID: 12892062
[TBL] [Abstract][Full Text] [Related]
11. Characterization of HIV type 1 subtype C protease gene: selection of L63P mutation in protease inhibitor-naive Indian patients.
Neogi U; Sahoo PN; Kumar R; De Costa A; Shet A
AIDS Res Hum Retroviruses; 2011 Nov; 27(11):1249-53. PubMed ID: 21453185
[TBL] [Abstract][Full Text] [Related]
12. Study of the genotypic resistant pattern in HIV-infected women and children from rural west Cameroon.
Turriziani O; Russo G; Lichtner M; Stano A; Tsague G; Maida P; Vullo V; Antonelli G
AIDS Res Hum Retroviruses; 2008 Jun; 24(6):781-5. PubMed ID: 18507527
[TBL] [Abstract][Full Text] [Related]
13. Prediction of drug-resistance in HIV-1 subtype C based on protease sequences from ART naive and first-line treatment failures in North India using genotypic and docking analysis.
Toor JS; Sharma A; Kumar R; Gupta P; Garg P; Arora SK
Antiviral Res; 2011 Nov; 92(2):213-8. PubMed ID: 21875619
[TBL] [Abstract][Full Text] [Related]
14. High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain: study of genotypic resistance.
Pérez-Alvarez L; Carmona R; Muñoz M; Delgado E; Thomson MM; Contreras G; Pedreira JD; Rodríguez Real R; Vázquez de Parga E; Medrano L; Taboada JA; Nájera R;
Antivir Ther; 2003 Aug; 8(4):355-60. PubMed ID: 14518705
[TBL] [Abstract][Full Text] [Related]
15. Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon.
Ragupathy V; Zhao J; Wood O; Tang S; Lee S; Nyambi P; Hewlett I
Virol J; 2011 Apr; 8():185. PubMed ID: 21513545
[TBL] [Abstract][Full Text] [Related]
16. Genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV/AIDS patients living in Liaoning Province, China: baseline prevalence and subtype-specific difference.
Han X; Zhang M; Dai D; Wang Y; Zhang Z; Liu J; Geng W; Jiang Y; Takebe Y; Shang H
AIDS Res Hum Retroviruses; 2007 Mar; 23(3):357-64. PubMed ID: 17411368
[TBL] [Abstract][Full Text] [Related]
17. V118I substitution in the reverse transcriptase gene of HIV type 1 CRF02_AG strains infecting drug-naive individuals in Cameroon.
Konings FA; Nyambi PN
AIDS Res Hum Retroviruses; 2004 Jun; 20(6):673-8. PubMed ID: 15242545
[TBL] [Abstract][Full Text] [Related]
18. Genotypic variation of HIV-1 reverse transcriptase and protease: comparative analysis of clade C and clade B.
Grossman Z; Vardinon N; Chemtob D; Alkan ML; Bentwich Z; Burke M; Gottesman G; Istomin V; Levi I; Maayan S; Shahar E; Schapiro JM;
AIDS; 2001 Aug; 15(12):1453-60. PubMed ID: 11504976
[TBL] [Abstract][Full Text] [Related]
19. Impact of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitors in HIV-1 non-B subtypes.
Holguín A; Paxinos E; Hertogs K; Womac C; Soriano V
J Clin Virol; 2004 Nov; 31(3):215-20. PubMed ID: 15465415
[TBL] [Abstract][Full Text] [Related]
20. The role of polymorphisms at position 89 in the HIV-1 protease gene in the development of drug resistance to HIV-1 protease inhibitors.
Martinez-Cajas JL; Wainberg MA; Oliveira M; Asahchop EL; Doualla-Bell F; Lisovsky I; Moisi D; Mendelson E; Grossman Z; Brenner BG
J Antimicrob Chemother; 2012 Apr; 67(4):988-94. PubMed ID: 22315096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
